Fused and Substituted Piperazines as Anticancer Agents: A Review
Chemical Biology & Drug Design · 2025-03 · 105 (3)
DOI: 10.1111/cbdd.70077 ↗At a glance
Übersichtsarbeit in Chemical Biology & Drug Design, published online on 2025-03-06. Written by Saumya Singh and 5 co-authors. Institution: Department of Pharmaceutical Chemistry, Noida Institute of Engineering and Technology (Pharmacy Institute), Greater Noida, India. Major MEDLINE topics: Antineoplastic Agents, Piperazines. Cited 14 times so far (Crossref); 101 references.
Abstract (original language)
Cancer is an abnormal and uncontrolled proliferation of normal cells. The availability of safer anticancer drugs with exceptional selectivity for healthy cells and great efficacy against various cancer forms continues to be a significant obstacle. The piperazine moiety is used as the building block of several molecules and is reported to have the ability to inhibit the cell cycle (G1/S phase), inhibit angiogenesis, and interact with DNA. Piperazine also has a flexible binding feature that allows it to interact with a variety of biological targets, which makes it effective against cancers. As there is a continuous need to obtain an anticancer drug with improved efficacy and fewer side effects, the piperazine derivatives attract the attention of researchers. This review highlights the recently reported methods of synthesis of fused/substituted piperazines, structure–activity relationship, and interactions with targets/receptors as anticancer agents. Thus, the presented review will help medicinal chemists in designing anticancer molecules with piperazines.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Pharmaceutical Chemistry, Noida Institute of Engineering and Technology (Pharmacy Institute), Greater Noida, India.
- School of Pharmacy, Graphic Era Hill University, Dehradun, India.
ORCID profiles: Rajnish Kumar
Cite
APA
Singh, S., Kumar, R., Tripathi, S., Salahuddin, Mazumder, A., & Singh, N. (2025). Fused and Substituted Piperazines as Anticancer Agents: A Review. Chemical Biology & Drug Design, 105(3). https://doi.org/10.1111/cbdd.70077
Vancouver
Singh S, Kumar R, Tripathi S, Salahuddin, Mazumder A, Singh N. Fused and Substituted Piperazines as Anticancer Agents: A Review. Chemical Biology & Drug Design. 2025;105(3). doi:10.1111/cbdd.70077
BibTeX
@article{Singh2025,
author = {Singh, Saumya and Kumar, Rajnish and Tripathi, Shrishti and Salahuddin and Mazumder, Avijit and Singh, Nardev},
title = {Fused and Substituted Piperazines as Anticancer Agents: A Review},
journal = {Chemical Biology & Drug Design},
year = {2025},
volume = {105},
number = {3},
doi = {10.1111/cbdd.70077}
}
EUVIMED